-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/qde-mmd-webinar-on_quality-measure-use.pdf
September 24, 2015 - Chlamydia screening
8. Dental visits
9. Preventive dental visits
10. BMI
11. … 96.67%
Children’s and Adolescents’ Access to Primary Care 93.33%
Dental Treatment Services 93.33%
Chlamydia
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/qde-mmd-webinar-on_quality-measure-use.pdf
September 24, 2015 - Chlamydia screening
8. Dental visits
9. Preventive dental visits
10. BMI
11. … 96.67%
Children’s and Adolescents’ Access to Primary Care 93.33%
Dental Treatment Services 93.33%
Chlamydia
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/qde-mmd-webinar-on_quality-measure-use.pdf
September 24, 2015 - Chlamydia screening
8. Dental visits
9. Preventive dental visits
10. BMI
11. … 96.67%
Children’s and Adolescents’ Access to Primary Care 93.33%
Dental Treatment Services 93.33%
Chlamydia
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/qde-mmd-webinar-on_quality-measure-use.pdf
September 24, 2015 - Chlamydia screening
8. Dental visits
9. Preventive dental visits
10. BMI
11. … 96.67%
Children’s and Adolescents’ Access to Primary Care 93.33%
Dental Treatment Services 93.33%
Chlamydia
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/qde-mmd-webinar-on_quality-measure-use.pdf
September 24, 2015 - Chlamydia screening
8. Dental visits
9. Preventive dental visits
10. BMI
11. … 96.67%
Children’s and Adolescents’ Access to Primary Care 93.33%
Dental Treatment Services 93.33%
Chlamydia
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/qde-mmd-webinar-on_quality-measure-use.pdf
September 24, 2015 - Chlamydia screening
8. Dental visits
9. Preventive dental visits
10. BMI
11. … 96.67%
Children’s and Adolescents’ Access to Primary Care 93.33%
Dental Treatment Services 93.33%
Chlamydia
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ndk2qMLMrpq_DLV5ddEQFd
August 22, 2023 - • A bacterial sexually transmitted infection (syphilis, gonorrhea, or chlamydia for men who have sex … • A bacterial sexually transmitted infection (STI) (syphilis, gon-
orrhea, or chlamydia for men who … syphi-
lis in pregnant24 and nonpregnant25 persons, screening for genital
herpes,26 screening for chlamydia … [n = 10 775]; RR,
1.08 [95% CI, 0.98-1.18]), gonorrhea (5 trials; RR, 1.07 [95% CI, 0.82-
1.39]), chlamydia … Screening
for chlamydia and gonorrhea: US Preventive
Services Task Force recommendation statement.
-
www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/genital-herpes-serologic-screening
August 16, 2022 - Behavioral counseling interventions to prevent STIs 14
Screening for chlamydia and gonorrhea 15
Screening … Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/sexually-transmitted-infections-behavioral-counseling
August 02, 2018 - papillomavirus (HPV), herpes simplex virus (HSV) type 1 and 2, hepatitis B and C viruses, Zika virus, chlamydia
-
www.ahrq.gov/research/findings/studies/index.html?page=46
January 01, 2024 - Continuing Medical Education, Education: Curriculum
Teixeira da Silva D , Petsis D , Santos T Chlamydia … This study describes retesting following Chlamydia trachomatis/Neisseria gonorrhea (CT/NG) diagnosis … Chlamydia trachomatis/neisseria gonorrhea retesting among adolescents and young adults in a primary care
-
www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/research/engaging-challenging-full.pdf
May 01, 2024 - /chlamydia-
and-gonorrhea-screening . … https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening … Chlamydia/gonorrhea Recommendation for general age group (grade B):57
▪ Screening in all sexually active … "healthy
diet" OR "lung cancer" OR
osteoporosis OR fracture* OR
"abdominal aortic aneurysm" OR
"chlamydia … "healthy
diet" OR "lung cancer" OR
osteoporosis OR fracture* OR
"abdominal aortic aneurysm" OR
"chlamydia
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
June 11, 2019 - 42
There were no significant differences between PrEP vs placebo or no PrEP in risk of gonorrhea, chlamydia … statistically significant interaction between PrEP regimen and any adverse event except for gonorrhea and chlamydia … an open-label RCT and nonrandomized studies found PrEP associated with an increased risk of rectal chlamydia … (4 studies; odds ratio, 1.59 [95% CI, 1.19-2.13]) but found no association between PrEP and risk of chlamydia … women
3 27 , 42 , 43
1.20 (0.76-1.92)
69
MSM
2 17 , 31
1.05 (0.85-1.30)
0
Chlamydia
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
June 11, 2019 - 42
There were no significant differences between PrEP vs placebo or no PrEP in risk of gonorrhea, chlamydia … statistically significant interaction between PrEP regimen and any adverse event except for gonorrhea and chlamydia … an open-label RCT and nonrandomized studies found PrEP associated with an increased risk of rectal chlamydia … (4 studies; odds ratio, 1.59 [95% CI, 1.19-2.13]) but found no association between PrEP and risk of chlamydia … women
3 27 , 42 , 43
1.20 (0.76-1.92)
69
MSM
2 17 , 31
1.05 (0.85-1.30)
0
Chlamydia
-
www.ahrq.gov/research/findings/studies/index.html?page=277
January 01, 2024 - Wynn A , Ramogola-Masire D , Gaolebale P Prevalence and treatment outcomes of routine Chlamydia … Prevalence and treatment outcomes of routine Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/AnLwG-T96XaL_TCZ6TPcWe
March 07, 2017 - diagnostic accuracy for any
gynecologic cancer or condition except cervical cancer, gonorrhea, and chlamydia … effective screening approaches are recommended
(eg, nucleic acid amplification test for gonorrhea and chlamydia … for cervical can-
cer (such as Papanicolaou and human papillomavirus cotesting)
and for gonorrhea and chlamydia … Cervical cancer,
gonorrhea, and chlamydia were not included because other effec-
tive screening tests … Screening for chlamydia and gonorrhea: U.S.
-
www.ahrq.gov/prevention/guidelines/guide/section2b.html
June 01, 2014 - Other Relevant USPSTF Recommendations
The USPSTF has made recommendations on screening for chlamydia … screening of pregnant women for other infections, including asymptomatic bacteriuria, bacterial vaginosis, chlamydia
-
www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/long-term-care/assess-resident-RTI-slides.pptx
June 01, 2021 - WBC
Chest films show infiltrates, possible effusions
*Bacterial causes include Mycoplasma pneumoniae, Chlamydia
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
August 22, 2023 - trials; n = 9296; RR, 1.07 [95% CI, 0.82-1.39]; I 2 = 49%) (eFigure 14 in the JAMA Supplement), chlamydia … Condomless anal sex with ≥2 partners in the previous 12 wk or syphilis, rectal gonorrhea, or rectal chlamydia … 0.91-1.06) Syphilis: 15% (413/2694) vs 15% (392/2693); RR, 1.05 (95% CI, 0.93-1.20) Urethral chlamydia … receiving PrEP
Moderate for no difference
See applicability for KQ1, oral PrEP vs placebo
Chlamydia … receiving PrEP
Moderate for no difference
See applicability for KQ1, oral PrEP vs placebo
Chlamydia
-
www.ahrq.gov/sites/default/files/wysiwyg/patients-consumers/prevention/lifestyle/healthy-women.pdf
May 01, 2014 - Get screened for chlamydia and gonorrhea
infections if you are 24 years or younger and
sexually active
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/publications2/files/measure-retirement-2013.pdf
January 01, 2013 - Chlamydia Screening in Women 0033 National Committee for Quality
Assurance
10. … Chlamydia Screening – sexually active females ages 16-20
– Number of female Medicaid/CHIP enrollees … Measure Name Chlamydia Screening in Women
4.b. … Chlamydia Screening in Women 6.75 (15) 6.50 (22) 5 No change
18. … Chlamydia Screening in Women
SNAC members expressed mixed sentiments about this measure.